Viagra knockoff
This article was originally published in The Tan Sheet
Executive Summary
FTC temporary court order prohibits David Brady (d.b.a. American Urological Corp., the Institute of Sexual Research, the New England Institute for Impotence and Prostate Care) from making unsubstantiated impotence treatment claims for products marketed as Alprostaglandin, Prosta-Gen and Vaegra. Brady falsely claims his products have been developed through legitimate medical studies. FTC says the company uses direct mail to market its products. Pfizer, the marketer of Viagra (sildenafil), won a lawsuit against Brady for trademark infringement ("The Tan Sheet" May 25, In Brief)...
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning